Announcements

A Form 4 filed with the SEC on September 4, 2026, discloses that Anthony Ping Leung Kam, a director of PDD Holdings Inc. (NASDAQ:PDD), sold 1,705 American depositary shares on September 3, 2026, at a price of $82.20 per ADS.

Gilmore Neil O'Neill, CEO and Director of Editas Medicine, Inc. (NASDAQ:EDIT), filed a Form 4 on September 4, 2026, disclosing the disposition of 5,124 shares of common stock on September 3, 2026, in connection with the vesting of restricted stock units.

Linda Burkly, Executive Vice President and Chief Scientific Officer of Editas Medicine, Inc. (NASDAQ:EDIT), filed a Form 4 on September 4, 2026, disclosing the sale of 709 shares of common stock on September 3, 2026, in connection with the vesting of restricted stock units.

Wupen Yuen, President of Global Business Units at Lumentum Holdings Inc., filed a Form 4 on September 4, 2026, disclosing the sale of 1,500 shares of common stock across three consecutive trading days under a pre-established Rule 10b5-1 trading plan.

Prashant B. Rawat, Chief Operating Officer of Mobia Medical, Inc. (NASDAQ:MOBI), filed a statement of changes in beneficial ownership on September 4, 2026, reporting a stock option exercise transaction dated September 2, 2026.

Ryan R. Craig, Executive Vice President and Chief Human Resources Officer of Elevance Health, Inc., filed a Form 4 on September 4, 2026, reporting a disposition of common stock on September 2, 2026, related to restricted stock vesting.

Erin M. Wessling, Executive Vice President and Chief Legal Officer of Elevance Health, Inc., filed a Form 4 on September 4, 2026, disclosing two transactions involving the withholding of common shares to cover tax liabilities upon the vesting of previously granted restricted stock.